Chemistry Reference
In-Depth Information
use of nitrocellulose as the reaction matrix. The lateral-
ow format is the only
ubiquitous, universally applicable platform that can be utilised for simple, quali-
tative, low cost point-of-care applications, while also having enough capability to
be functionalised for highly sensitive, fully quanti
fl
ed, multiplexed assays. Hence,
the industrial partners are seeking technologies that have improved capabilities,
sensitivity, speci
city, and compatibility with the existing manufacturing processes.
Only low cost is not enough to achieve market penetration in diagnostics. The value
of the low-cost and multiplexed diagnostics will be realised upon reaching com-
munities, where they are needed the most.
References
1. Hagist C, Kotlikoff LJ (2009) Who
'
s going broke? Comparing growth in public healthcare
expenditure in ten OECD countries. Hacienda Publica Esp 188:55
-
72
2. Which path will you take? (2007). Pharma 2020: The vision. PricewaterhouseCoopers
3. Medicines and older people implementing medicines-related aspects of the NSF for older
people (2001) Department of Health, United Kingdom, 23634
4. Whitesides GM (2009) A lab the size of a postage stamp, TEDX Boston.
http://www.ted.com
.
Accessed 27 Oct 2014
5. Akram MS, Daly R, Vasconcellos FC, Yetisen AK, Hutchings I, Hall EAH (2015)
Applications of paper-based diagnostics. In: Castillo-Leon J, Svendsen WE (eds) Lab-on-a-
chip devices and micro-total analysis systems. Springer
6. Nkengasong JN, Mesele T, Orloff S, Kebede Y, Fonjungo PN, Timperi R, Birx D (2009)
Critical role of developing national strategic plans as a guide to strengthen laboratory health
systems in resource-poor settings. Am J Clin Pathol 131(6):852
857. doi:
10.1309/AJCPC51
-
7. Schull MJ, Banda H, Kathyola D, Fairall L, Martiniuk A, Burciul B, Zwarenstein M, Sodhi
S, Thompson S, Joshua M, Mondiwa M, Bateman E (2010) Strengthening health human
resources and improving clinical outcomes through an integrated guideline and educational
outreach in resource-poor settings: a cluster-randomized trial. Trials 11:118. doi:
10.1186/
8. Lee HH, Allain JP (2004) Improving blood safety in resource-poor settings. Vox Sang 87
9. Allegranzi B, Nejad SB, Combescure C, Graafmans W, Attar H, Donaldson L, Pittet D
(2011) Burden of endemic health-care-associated infection in developing countries:
systematic review and meta-analysis. Lancet 377(9761):228
241. doi:
10.1016/S0140-6736
-
10. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA,
Buchsbaum S, Moeller G, Burgess DCH (2006) Requirements for high impact diagnostics in
the developing world. Nature 444(Suppl 1):73
79. doi:
10.1038/nature05448
11. Newton PN, Green MD, Fernandez FM, Day NPJ, White NJ (2006) Counterfeit anti-
infective drugs. Lancet Infect Dis 6(9):602
-
613. doi:
10.1016/S1473-3099(06)70581-3
12. Yager P, Domingo GJ, Gerdes J (2008) Point-of-care diagnostics for global health. Annu Rev
Biomed Eng 10:107
-
144. doi:
10.1146/annurev.bioeng.10.061807.160524
13. Mao X, Huang TJ (2012) Microfluidic diagnostics for the developing world. Lab Chip 12
14. Water quality for ecosystem and human health (2008) 2 edn. GEMS/Water programme
of
ce, UN, Burlington, Ontario, Canada
-
